Patents by Inventor Murray Thomson

Murray Thomson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • MUNITIONS AND PROJECTILES
    Publication number: 20220065597
    Abstract: According to an aspect of the invention, there is provided a system for reducing water-entry shock for a projectile entering the water, the system comprising: a first component, the first component being moveable to a target region for which water-entry shock is to be reduced, and arranged to interact with the water, for reducing water-entry shock for a second component; a second component in the form of the projectile, arranged to enter the water in the region for which water-entry shock has been reduced by the first component, functionality of the second projectile component being triggered by the water.
    Type: Application
    Filed: December 18, 2019
    Publication date: March 3, 2022
    Applicant: BAE SYSTEMS plc
    Inventors: Andrew Carr, Timothy Keith Girling, Thomas Patrick O'Neill, Murray Thomson
  • PROGRAMMABLE SYSTEM AND METHOD FOR A MUNITION
    Publication number: 20220049943
    Abstract: According to a first aspect of the invention, there is provided a programmable system for a munition, comprising: an electroacoustic transducer, arranged to receive an acoustic signal comprising data, and convert that signal into an electrical signal comprising data; a processor, arranged to receive and process the electrical signal comprising data, and to use that data in programming of the programmable system.
    Type: Application
    Filed: December 17, 2019
    Publication date: February 17, 2022
    Applicant: BAE SYSTEMS plc
    Inventors: Andrew Carr, Murray Thomson, Timothy Keith Girling, Martyn John Hucker
  • Sulfonamide derivatives for the treatment of diseases
    Patent number: 8013019
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: July 1, 2010
    Date of Patent: September 6, 2011
    Assignee: Pfizer Inc
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Sulfonamide Derivatives For The Treatment Of Diseases
    Publication number: 20100273758
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: July 1, 2010
    Publication date: October 28, 2010
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Sulfonamide derivatives for the treatment of diseases
    Patent number: 7767715
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: April 8, 2009
    Date of Patent: August 3, 2010
    Assignee: Pfizer Inc
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Sulfonamide Derivatives for the Treatment of Diseases
    Publication number: 20090197912
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: April 8, 2009
    Publication date: August 6, 2009
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Sulfonamide derivatives for the treatment of diseases
    Patent number: 7528170
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: July 3, 2007
    Date of Patent: May 5, 2009
    Assignee: Pfizer Inc.
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Infrared Light Sensors for Diagnosis and Control of Industrial Furnaces
    Publication number: 20090102103
    Abstract: Passive sensors, and more particularly passive infrared sensors are used to ascertain the signature of carbon dioxide and carbon monoxide in the infrared region of the light emitted by the exhaust gas and dust particles of industrial furnaces. The targeted sectors for which the sensors are to be used include steel-making, cement industries and thermal power generation, and others where combustion efficiency and the production of GHGs would be of a concern.
    Type: Application
    Filed: March 6, 2007
    Publication date: April 23, 2009
    Inventors: Murray Thomson, Salvador Rego-Barcena
  • Sulfonamide Derivatives For The Treatment of Diseases
    Publication number: 20080267970
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Application
    Filed: July 3, 2007
    Publication date: October 30, 2008
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Process for the Preparation of Sulfonamide Derivatives
    Publication number: 20080193988
    Abstract: The invention relates to a process for the preparation of compounds of formula (I) wherein Q1 is a group selected from formulae (II) & (III) and a group *-NR6-Q2-A or, if appropriate, their pharmaceutically acceptable salts and/or isomers, tautomers, solvates or isotopic variations thereof, as well as intermediates used in said process.
    Type: Application
    Filed: July 10, 2006
    Publication date: August 14, 2008
    Inventors: Iain Robert Gladwell, Pieter David De Koning, Ian Brian Moses, Alan John Pettman, Nicholas Murray Thomson
  • Sulfonamide derivatives for the treatment of diseases
    Patent number: 7351742
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: April 1, 2008
    Assignee: Pfizer Inc.
    Inventors: Alan Daniel Brown, Kim James, Charlotte Alice Louise Lane, Ian Brian Moses, Nicholas Murray Thomson
  • Sulfonamide derivatives for the treatment of diseases
    Patent number: 7244766
    Abstract: The invention relates to compounds of formula (1) and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of, such derivatives. The compounds according to the present invention are useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.
    Type: Grant
    Filed: January 19, 2005
    Date of Patent: July 17, 2007
    Assignee: Pfizer Inc
    Inventors: Alan Daniel Brown, Mark Edward Bunnage, Paul Alan Glossop, Kim James, Charlotte Alice Louise Lane, Russel Andrew Lewthwaite, Ian Brian Moses, David Anthony Price, Nicholas Murray Thomson
  • Process for the preparation of pyrazolopyrimidinones
    Patent number: 7067660
    Abstract: There is provided a process for the production a compound of general formula I: wherein A, R1, R2, R3 and R4 have meanings given in the description, which process comprises the dehydrogenation of a compound of general formula II,
    Type: Grant
    Filed: December 1, 2003
    Date of Patent: June 27, 2006
    Assignee: Pfizer Inc.
    Inventors: Mark Edward Bunnage, Philip Charles Levett, Nicholas Murray Thomson
  • 3-heterocyclylpropanohydroxamic acids
    Patent number: 6897306
    Abstract: Compounds of formula (I): and their salts, solvates, prodrugs, etc., wherein the substituents have the values mentioned herein, are Procollagen C-Proteinase (PCP) inhibitors and have utility in conditions mediated by PCP.
    Type: Grant
    Filed: July 16, 2002
    Date of Patent: May 24, 2005
    Assignee: Pfizer Products, Inc.
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • Olefination process to itaconate and succinate derivatives
    Patent number: 6750363
    Abstract: An efficient and selective process, capable of scale-up, to make itaconate derivatives of formula (IV), and/or succinate derivatives of formula (V) and/or (VI) by asymmetric hydrogenation of the itaconate derivatives. wherein R, R1 and R2 are as defined herein.
    Type: Grant
    Filed: July 18, 2002
    Date of Patent: June 15, 2004
    Assignee: Pfizer, Inc.
    Inventors: Andrew Michael Derrick, Nicholas Murray Thomson
  • Novel process for the preparation of pyrazolopyrimidinones
    Publication number: 20040110948
    Abstract: There is provided a process for the production a compound of general formula I: 1
    Type: Application
    Filed: December 1, 2003
    Publication date: June 10, 2004
    Applicant: Pfizer Inc
    Inventors: Mark Edward Bunnage, Philip Charles Levett, Nicholas Murray Thomson
  • Process for the preparation of pyrazolopyrimidinones
    Patent number: 6730786
    Abstract: There is provided a process for the production a compound of general formula I: wherein A, R1, R2, R3 and R4 have meanings given in the description, which process comprises the dehydrogenation of a compound of general formula II,
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: May 4, 2004
    Assignee: Pfizer Inc
    Inventors: Mark Edward Bunnage, Philip Charles Levett, Nicholas Murray Thomson
  • 3-Heterocyclylpropanohydroxamic acids
    Publication number: 20030119807
    Abstract: Compound of formula (I): 1
    Type: Application
    Filed: July 16, 2002
    Publication date: June 26, 2003
    Inventors: Simon Bailey, Stephane Billotte, Paul Vincent Fish, Kim James, Nicholas Murray Thomson, Andrew Michael Derrick
  • Metalloprotease inhibitors
    Patent number: 6511993
    Abstract: Compounds of formula (I) and pharmaceutically-acceptable derivatives thereof, are matrix metalloprotease inhibitors, useful in treatment of conditions mediated by matrix metalloproteases, such as chronic dermal ulcers.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: January 28, 2003
    Inventors: Kevin Neil Dack, Michael Jonathan Fray, Gavin Alistair Whitlock, Mark Llewellyn Lewis, Nicholas Murray Thomson
  • Novel olefination process to itaconate and succinate derivatives
    Publication number: 20020188121
    Abstract: An efficient and selective process, capable of scale-up, to make itaconate derivatives of formula (IV), and/or succinate derivatives of formula (V) and/or (VI) by asymmetric hydrogenation of the itaconate derivatives.
    Type: Application
    Filed: July 18, 2002
    Publication date: December 12, 2002
    Inventors: Andrew Michael Derrick, Nicholas Murray Thomson